FSMAX
Price
$103.54
Change
+$1.43 (+1.40%)
Updated
Feb 3 closing price
Net Assets
40.63B
SDSCX
Price
$23.36
Change
-$9.11 (-28.06%)
Updated
Feb 3 closing price
Net Assets
910.78M
Interact to see
Advertisement

FSMAX vs SDSCX

Header iconFSMAX vs SDSCX Comparison
Open Charts FSMAX vs SDSCXBanner chart's image
Fidelity Extended Market Index
Price$103.54
Change+$1.43 (+1.40%)
VolumeN/A
Net Assets40.63B
BNY Mellon Sm/Md Cp Gr I
Price$23.36
Change-$9.11 (-28.06%)
VolumeN/A
Net Assets910.78M
FSMAX vs SDSCX Comparison Chart in %
View a ticker or compare two or three
VS
FSMAX vs. SDSCX commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and SDSCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40.6B vs. SDSCX (911M). FSMAX pays higher dividends than SDSCX: FSMAX (0.56) vs SDSCX (0.00). FSMAX was incepted earlier than SDSCX: FSMAX (14 years) vs SDSCX (38 years). SDSCX (0.77) is less costly to investors than FSMAX (0.04). SDSCX is a more actively managed with annual turnover of: 48.92 vs. FSMAX (15.00). FSMAX has a lower initial minimum investment than SDSCX: FSMAX (0) vs SDSCX (1000). FSMAX annual gain was more profitable for investors over the last year : 10.51 vs. SDSCX (-24.18). FSMAX return over 5 years is better than : 19.23 vs. SDSCX (-44.89).
FSMAXSDSCXFSMAX / SDSCX
Total Expense Ratio0.040.725%
Annual Report Gross Expense Ratio0.040.775%
Fund Existence14 years38 years-
Gain YTD3.0509.41532%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets40.6B911M4,457%
Annual Yield % from dividends0.560.00-
Returns for 1 year10.51-24.18-43%
Returns for 3 years48.06-8.54-563%
Returns for 5 years19.23-44.89-43%
Returns for 10 years157.0268.91228%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SIMAU10.79N/A
N/A
SIM Acquisition Corp
TRDA11.79-0.06
-0.51%
Entrada Therapeutics
KN24.59-0.55
-2.19%
KNOWLES Corp
ANVS2.60-0.10
-3.70%
Annovis Bio
AMKR46.24-1.96
-4.07%
Amkor Technology